Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA] includes 2 drugs with a combined 2,734 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
2,734
Combined Reports
All Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| TENAPANOR | IBSRELA | 1,935 | 332 | 568 | 17.2% |
| MARALIXIBAT | Livmarli | 799 | 14 | 98 | 1.8% |
Common Side Effects in Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Diarrhoea | 864 | 30 |
| Pruritus | 238 | 3 |
| Death | 228 | 226 |
| Off label use | 204 | 6 |
| Hospitalisation | 138 | 25 |
| Inappropriate schedule of product administration | 115 | 1 |
| Drug ineffective | 98 | 2 |
| Vomiting | 82 | 1 |
| Product use issue | 78 | 2 |
| Abdominal pain | 74 | 3 |